RE:Is anybody else contemplating to double down at .035?
CriticalMind55 wrote: Another opportunity that I see for SCRN is a strong team of nurses and doctors that can be deployed to anywhere in the world to provide many different services given different situations, so their business will not be all end all COVID, possibilities are endless and sustainable, reoccurring revenue beyond COVID is achievable.
I'm happy with the cancellation of the deal with Centred, I think it was McMullen's idea but not Ryu's. We have had several news this week which gives us a good overview of the situation. I believe Ryu is working to reverse the trend quickly and I expect more news in the near term which may confirm the double low at .035 and start rising again and restore confidence. In terms of deploying the SCRN teams around the world, there was the news of March 10 which was related to what you are suggesting, however we have not had any new information on this so we should ask Ryu about it.
ScreenPro Approved to Bid on NHS London UK Supply Tender
Toronto, Ontario - March 10, 2021 - Compel Capital o/a ScreenPro Security (CSE: SCRN) ("ScreenPro" or the "Company"), is pleased to inform its shareholders that the company, through its partnership with Enoura Medical in United Kingdom, has been approved by the National Health Service (NHS) in London UK and is now eligible to bid on NHS contracts by offering its suite of services and products.
The NHS of London is the medical agency for the City of London tasked with ensuring the medical health and safety of all of its 9.4 million citizens. To become a qualified supplier, the entity and its product offering have to be stringently reviewed and approved by the National Health Service (NHS) prior to bidding.
Enoura Medical has been working with ScreenPro for the last five months positioning the Company to provide solutions to the growing issues challenging London. For example, it is estimated that the overall value of the NHS tender for the city of London alone, is over 900 million GBP (equivalent to $1.574 Billion CDN) and illustrates how the country is preparing to screen its citizens for all variants of the virus for the next two years.